Conscience Labs is a company that researches, develops, produces, and commercializes stable and homogeneous substances (APIs) with psychedelic characteristics composed of simple or complex molecules and compounds oriented to the pharma industry complying with GMP standards.

Our core operation is the production of API substances and B2B white-label sales. The products to be marketed are simple or complex molecules and compounds that are equal to or similar to DMT, LSD, MDMA, Psilocybin, and Mescaline.